The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.
D001407:Bacillus; D035843:Biomedical Research; D006094:Gram-Positive Bacteria; D007538:Isoniazid; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D009539:Nicotinic Acids; D009525:Niacin; D007538:Isoniazid
MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy